OCLN and inflammatory bowel disease: IL-1β consistently increased intestinal permeability in vitro and in vivo, partly by MLCK overexpression and miR200c-3p-mediated occludin degradation, with antagonism of miR200c-3p improving clinical outcomes in murine IBD models [141].